Skip to main content
Log in

Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery

A validation study

  • Articles
  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

Computer-assisted quantitative coronary arteriography (QCA) has gained widespread acceptance in assessing changes in coronary dimensions over time, but little is known about the utility of QCA in patients having undergone coronary bypass surgery. As a validation study, we analyzed the accuracy and precision of QCA in a subset of the baseline angiograms of a clinical trial in 395 post-bypass men with low HDL cholesterol concentrations who have been randomized to receive double-blind gemfibrozil or placebo for 2 1/2 years. Based on repeat measurements of the same cineframe, the average diameter of a segment (ADS) had a mean coefficient of variation (CV) of 3.1 %. The mean CVs of the minimum luminal diameter (MLD), percent diameter stenosis (PDS) and stenotic flow reserve of an obstruction were 8.6, 10.2 and 9.8%, respectively, but the area of the atherosclerotic plaque had an unacceptably high CV, 24.0%. When the measurements from two contrast injections into a native coronary artery during the same angiographic session were compared, precision (standard deviation of the differences) was 0.198 mm for ADS, 0.192 mm for MLD, and 7.37% for PDS. Variability was not substantially reduced when measurements from 3 or 5 consecutive cineframes were averaged. Comparable repeatability was found when venous bypass grafts were imaged twice, whether the grafts themselves or the grafted native vessels were analyzed. We conclude that QCA has an acceptable accuracy and precision in analyzing coronary dimensions in bypass-grafted patients. A change of 0.40 mm in ADS and MLD, and 20% in PDS represent true progression or regression of coronary atherosclerosis with more than 95% confidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CAD:

coronary artery disease

CMS:

Cardiovascular Measurement System

MLD:

minimum luminal diameter (of an obstruction)

ADS:

average diameter of a segment

PDS:

percent diameter stenosis (of an obstruction)

QCA:

quantitative coronary arteriography

SFR:

stenotic flow reserve (of an obstruction)

References

  1. De Feyter PJ, Serruys PW, Davies MJ, Richardson P, Lubsen J, Oliver ME. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials. Circulation 1991; 84: 412–23.

    Google Scholar 

  2. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin J-T, Kaplan C, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289–98.

    Google Scholar 

  3. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129–33.

    Google Scholar 

  4. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007–12.

    Google Scholar 

  5. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563–9.

    Google Scholar 

  6. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990; 335: 1109–13.

    Google Scholar 

  7. Waters D, Lespérance J, Francetich M, Causey D, Théroux P, Chiang YK, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940–53.

    Google Scholar 

  8. Reiber JHC. Morphologic and densitometric quantitation of coronary stenoses: An overview of existing quantitation techniques. In: Reiber JHC, Serruys PW, (eds). New developments in quantitative coronary arteriography. Dordrecht: Kluwer Academic Publishers, 1988: 34–88.

    Google Scholar 

  9. Reiber JHC, van der Zwet PMJ, von Land CD, Koning G, van Meurs B, Buis B, van Voorthuisen AE. Quantitative coronary arteriography: Equipment and technical requirements. In: Reiber JHC, Serruys PW, (eds). Advances in quantitative coronary arteriography. Dordrecht: Kluwer Academic Publishers, 1993: 75–111.

    Google Scholar 

  10. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from compute-rassisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–8.

    Google Scholar 

  11. Reiber JHC, den Boer A, Serruys P. Quality control in performing quantitative coronary arteriography. Am J Cardiac Imaging 1989; 3: 172–9.

    Google Scholar 

  12. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40.

    Google Scholar 

  13. Lespérance J, Waters D. Measuring progression and regression of coronary atherosclerosis in clinical trials: Problems and progress. Int J Cardiac Imaging 1992; 8: 165–73.

    Google Scholar 

  14. Frick MH, Valle M, Harjola P-T. Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol 1983; 52: 681–5.

    Google Scholar 

  15. Jost S, Deckers JW, Nikutta P, Rafflenbeul W, Wiese B, Hecker H, et al. Progression of coronary artery disease is dependent on anatomic location and diameter. J Am Coll Cardiol 1993; 21: 1339–46.

    Google Scholar 

  16. Ellis S, Sanders W, Goulet C, Miller R, Cain KC, Lespérance J, et al. Optimal detection of the progression of coronary artery disease: Comparison of methods suitable for risk factor intervention trials. Circulation 1986; 74: 1235–42.

    Google Scholar 

  17. Selzer RH, Hagerty C, Azen SP, Sieber M, Lee P, Shircore A, Blankenhorn DH. Precision and reproducibility of quantitative coronary angiography with applications to controlled clinical trials: A sampling study. J Clin Invest 1989; 83: 520–6.

    Google Scholar 

  18. Gould KL. Quantification of coronary artery stenosis in vivo. Circ Res 1985; 57: 341–53.

    Google Scholar 

  19. Kirkeeide RL, Gould KL, Parsel L. Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions. J Am Coll Cardiol 1986; 7: 103–13.

    Google Scholar 

  20. Brown BG, Lin JT, Kelsey S, Passamani ER, Levy RI, Dodge HT, Dette KM. Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia: Quantitative artériographie assessment of patients in the NHLBI Type II Study. Arteriosclerosis 1989; 9 (Suppl 1): I-81–I-90.

    Google Scholar 

  21. Lamm C, Donnal M, Serruys PW, Emanuelsson H. High-fidelity translesional pressure gradients during percutaneous transluminal coronary angioplasty: Correlation with quantitative coronary angiography. Am Heart J 1993; 126: 66–75.

    Google Scholar 

  22. Jost S, Deckers J, Rafflenbeul W, Hecker H, Reiber JHC, Nikutta P, et al. International nifedipine trial on anti-atherosclerotic therapy (INTACT) — methodological implications and results of a coronary angiographic follow-up study using compute-rassisted film analysis. Int J Cardiac Imaging 1990/91; 6: 117–33.

    Google Scholar 

  23. Stiel GM, Stiel LSG, Schofer J, Donath K, Mathey DG. Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. Circulation 1989; 80: 1603–9.

    Google Scholar 

  24. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213–20.

    Google Scholar 

  25. Gibson CM, Sandor T, Stone PH, Pasternak RC, Rosner B, Sacks FM. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol 1992; 69: 1286–90.

    Google Scholar 

  26. Reiber JHC, van Eldik-Helleman P, Kooijman CJ, Tijssen JGP, Serruys PW. How critical is frame selection in quantitative coronary angiographic studies? Eur Heart J 1989; 10 (Suppl F): 54–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Syvänne, M., Nieminen, M.S. & Frick, M.H. Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. Int J Cardiac Imag 10, 243–252 (1994). https://doi.org/10.1007/BF01137715

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01137715

Key words

Navigation